162 related articles for article (PubMed ID: 28760534)
1. An analysis of factors related to the effect of sublingual immunotherapy on Japanese cedar pollen induced allergic rhinitis.
Yonekura S; Okamoto Y; Sakurai D; Okubo K; Gotoh M; Kaneko S; Konno A
Allergol Int; 2018 Apr; 67(2):201-208. PubMed ID: 28760534
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
[TBL] [Abstract][Full Text] [Related]
3. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
Gotoh M; Yonekura S; Imai T; Kaneko S; Horikawa E; Konno A; Okamoto Y; Okubo K
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
[TBL] [Abstract][Full Text] [Related]
5. Sublingual immunotherapy for allergic rhinitis: subjective versus objective tools to evaluate its success.
Sakurai D; Yonekura S; Iinuma T; Sakurai T; Morimoto Y; Mita Y; Arai T; Suzuki S; Okuma Y; Kaneko S; Okamoto Y
Rhinology; 2016 Sep; 54(3):221-30. PubMed ID: 27107025
[TBL] [Abstract][Full Text] [Related]
6. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
Yamanaka K; Shah SA; Sakaida H; Yamagiwa A; Masuda S; Mizutani H; Takeuchi K
Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
[TBL] [Abstract][Full Text] [Related]
7. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.
Yonekura S; Gotoh M; Kaneko S; Kanazawa K; Takeuji Y; Okubo K; Okamoto Y
Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168
[TBL] [Abstract][Full Text] [Related]
8. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
[TBL] [Abstract][Full Text] [Related]
9. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy.
Otsuka K; Otsuka H; Matsune S; Okubo K
Immun Inflamm Dis; 2020 Sep; 8(3):333-341. PubMed ID: 32468704
[TBL] [Abstract][Full Text] [Related]
10. Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen.
Ueda S; Ito J; Harada N; Harada S; Sasano H; Sandhu Y; Tanabe Y; Abe S; Shiota S; Kodama Y; Nagaoka T; Makino F; Chiba A; Akiba H; Atsuta R; Miyake S; Takahashi K
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454107
[TBL] [Abstract][Full Text] [Related]
11. [A MULTICENTER CLINICAL SURVEY ABOUT THE PREVALENCE OF JAPANESE CYPRESS POLLINOSIS AND THE EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH JAPANESE CEDAR POLLEN EXTRACT DURING JAPANESE CYPRESS POLLEN DISPERSAL PERIOD].
Oka A; Yuta A; Okawa Y; Masuno S; Tsunoda T; Takahara E; Terada A; Kanai K; Nagakura H; Mimura H; Arao H; Ueyama S; Ueyama A; Tokuda R; Bamba H; Nakazato H; Nakazato M; Amesara R; Nakai S; Araki S; Sakaida M; Tokuriki M; Hama T; Chiba M; Ikeda H; Togawa A; Tsuzuki H; Hyo Y; Niitsu S; Ohkawa C; Nakamoto S; Takeo T; Kumanomidou H; Kanai K; Kitamura H; Sugiura R; Okano M
Arerugi; 2023; 72(9):1138-1146. PubMed ID: 37967960
[TBL] [Abstract][Full Text] [Related]
12. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
Mitobe Y; Yokomoto Y; Ohashi-Doi K
Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
[TBL] [Abstract][Full Text] [Related]
13. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
Hamada S; Kobayashi Y; Sakamoto D; Shimamura A; Kuroda K; Kawachi R; Kanda A; Asako M; Gotoh M; Okubo K; Tomoda K; Iwai H
Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319
[TBL] [Abstract][Full Text] [Related]
14. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
[TBL] [Abstract][Full Text] [Related]
15. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood.
Nomura T; Suzuki M; Yokota M; Nakamura Y; Ozeki K; Ito Y; Tsuge I; Saitoh S
Ann Allergy Asthma Immunol; 2016 Jul; 117(1):72-78.e4. PubMed ID: 27156747
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial.
Nomura Y; Okubo K; Nakamura T; Sawaki S; Kitagou H; Idei N; Kaneko S; Kobayashi S; Tanaka Y; Okamoto Y
Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209
[TBL] [Abstract][Full Text] [Related]
17. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE THIRD TREATED YEAR WITH JAPANESE CEDAR POLLINOSIS IN 2017].
Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Ohta N; Kozaki H; Shimizu T
Arerugi; 2017; 66(9):1172-1180. PubMed ID: 29129888
[TBL] [Abstract][Full Text] [Related]
18. Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis.
Gotoh M; Kaminuma O; Nakaya A; Katayama K; Motoi Y; Watanabe N; Saeki M; Nishimura T; Kitamura N; Yamaoka K; Okubo K; Hiroi T
Int Immunol; 2017 Jun; 29(6):291-300. PubMed ID: 28575522
[TBL] [Abstract][Full Text] [Related]
19. [ENHANCED CLINICAL EFFECTS OF CEDARCURE
Yuta A; Ogawa Y; Murao T; Kozaki H; Shimizu T
Arerugi; 2022; 71(9):1122-1128. PubMed ID: 36372423
[TBL] [Abstract][Full Text] [Related]
20. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH CEDAR POLLEN IN A YEAR OF MASSIVE CEDAR POLLEN DISPERSAL AND ITS EFFECT ON JAPANESE CYPRESS POLLINOSIS].
Yuta A; Ogawa Y; Kozaki H; Shimizu T
Arerugi; 2023; 72(10):1230-1239. PubMed ID: 38092399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]